Second-Line Treatment of Ovarian Cancer

Oncologist - United States
doi 10.1634/theoncologist.5-1-26
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Alphamed Press

Related search

Second-Line Treatment for Renal Cell Cancer

British Journal of Cancer
Cancer ResearchOncology
2012English

Second-Line Treatment of Advanced Gastric Cancer: Where Do We Stand?

Journal of the National Comprehensive Cancer Network : JNCCN
MedicineOncology
2015English

Pazopanib as a Second Line Treatment for Uterine and Ovarian Carcinosarcoma: A Single Institutional Study

Journal of Gynecologic Oncology
MedicineGynecologyOncologyObstetrics
2017English

Second-Line Option for Colorectal Cancer

Cancer Discovery
Oncology
2015English

Extending the Platinum‐Free Interval in Recurrent Ovarian Cancer: The Role of Topotecan in Second‐Line Chemotherapy

Oncologist
Cancer ResearchMedicineOncology
1999English

Second-Line Treatment Options in Hepatocellular Carcinoma

Drugs in Context
Molecular MedicinePharmacology
2019English

The Unexpected Success of NRTIs in Second-Line Treatment

The Lancet Infectious Diseases
Infectious Diseases
2018English

Bevacizumab in the Treatment of Ovarian Cancer

Biologics: Targets and Therapy
OncologyImmunologyGastroenterologyPharmacologyRheumatologyAllergy
2011English

Second-Line Treatment of Non-Small Cell Lung Cancer: Focus on the Clinical Development of Dacomitinib

Frontiers in Medicine
Medicine
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy